Christensen, Britt <br/><br/>
Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.  [electronic resource] 

 -  Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association  02 2019 
 - 486-493 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1542-7714 
<br/><br/><label>Standard No.: </label>10.1016/j.cgh.2018.04.060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Calcineurin Inhibitors--administration & dosage<br/>Cyclosporine--administration & dosage<br/>Drug Therapy, Combination--adverse effects<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Male<br/>Prospective Studies<br/>Tacrolimus--administration & dosage<br/>Treatment Outcome<br/>Young Adult